In prostate cancer, FASN overexpression increases palmitate ester synthesis and stabilizes β-catenin accumulation through Wnt-1-mediated palmitoylation, driving oncogenesis (Figure 3C) (170). The gene discussed is FASN; the disease is prostate cancer.